Ken Griffin’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,700
Closed -$215K 10191
2019
Q3
$215K Sell
7,700
-107,800
-93% -$1.75M ﹤0.01% 8059
2019
Q2
$1.63M Buy
+115,500
New +$1.1M ﹤0.01% 4870

Ken Griffin's DOVA Position: Q4 2019 in Review

Ken Griffin sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 7,214 shares — an estimated $202K sold.

Ken Griffin first reported a position in DOVA in Q2 2018 and held it in 5 quarters. The position peaked at $1.73M in Q2 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Ken Griffin reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Ken Griffin sold 7,214 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $202K.
  • Ken Griffin first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
  • Ken Griffin's Dova Pharmaceuticals, Inc. Common Stock position peaked at $1.73M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.